ArticleRheumatology and immunology research2025

Predicting response to infliximab and interferon-α in Behçet's syndrome: An exploratory analysis from the BIO-BEHÇET'S randomized controlled trial.

Robert J Moots et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.